Share

October 01, 1996; 47 (4) ARTICLES

Fibroblasts of patients affected by Down's syndrome oversecrete amyloid precursor protein and are hyporesponsive to protein kinase C stimulation

S. Govoni, S. Bergamaschi, L. Gasparini, C. Quaglia, M. Racchi, E. Cattaneo, G. Binetti, A. Bianchetti, F. Giovetti, F. Battaini, M. Trabucchi
First published October 1, 1996, DOI: https://doi.org/10.1212/WNL.47.4.1069
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
24

Share

Article Information

vol. 47 no. 4 1069-1075
DOI: 
https://doi.org/10.1212/WNL.47.4.1069
PubMed: 
8857747
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
0028-3878
Online ISSN: 
1526-632X
History: 
  • First Published October 1, 1996.
Copyright & Usage: 
Copyright 1996 by Advanstar Communications Inc.

Author Disclosures

    1. S. Govoni, PhD,
    2. S. Bergamaschi, PhD,
    3. L. Gasparini, PhD,
    4. C. Quaglia, PhD,
    5. M. Racchi, PhD,
    6. E. Cattaneo, PhD,
    7. G. Binetti, MD,
    8. A. Bianchetti, MD,
    9. F. Giovetti, MD,
    10. F. Battaini, PhD and
    11. M. Trabucchi, MD
  1. S. Govoni, PhD,
  2. S. Bergamaschi, PhD,
  3. L. Gasparini, PhD,
  4. C. Quaglia, PhD,
  5. M. Racchi, PhD,
  6. E. Cattaneo, PhD,
  7. G. Binetti, MD,
  8. A. Bianchetti, MD,
  9. F. Giovetti, MD,
  10. F. Battaini, PhD and
  11. M. Trabucchi, MD
  1. From the Institute of Pharmacology (Dr. Govoni), University of Pavia; Institute of Pharmacological Sciences (Drs. Bergamaschi, Gasparini, Quaglia, Racchi, and Cattaneo), University of Milano; Alzheimer's Department (Drs. Racchi, Binetti, and Bianchetti), Sacred Heart Hospital of Brescia; Hospital Institute of Sospiro (Dr. Giovetti), Cremona; and the Department of Experimental Medicine and Biochemical Sciences (Drs. Battaini and Trabucchi), University of Roma Tor Vergata, Italy.
  2. Supported by grants from the Regione Lombardia and the Ministry of Health of Italy.
  3. Received September 22, 1995. Accepted in final form February 13, 1996.
  4. Address correspondence and reprint requests to Dr. Stefano Govoni, c/o Institute of Pharmacological Sciences, Univ. of Milano, Via Balzaretti 9, 20133 Milano, Italy.
View Full Text

Article usage

Article usage: November 2000 to May 2020

AbstractFullPdfSource
Nov 2000200Highwire
Jan 2001100Highwire
Apr 2001200Highwire
May 2001100Highwire
Nov 2001100Highwire
Dec 2001200Highwire
Jan 2002100Highwire
Jun 2003100Highwire
Jul 2003300Highwire
Aug 2003300Highwire
Sep 2003700Highwire
Oct 2003300Highwire
Nov 2003200Highwire
Dec 2003400Highwire
Jan 2004400Highwire
Feb 2004300Highwire
Mar 2004300Highwire
Apr 2004300Highwire
May 2004600Highwire
Jun 2004700Highwire
Jul 2004500Highwire
Aug 2004500Highwire
Oct 2004500Highwire
Nov 2004300Highwire
Dec 2004400Highwire
Jan 2005600Highwire
Feb 2005600Highwire
Mar 2005600Highwire
Apr 2005300Highwire
May 20051300Highwire
Jun 2005500Highwire
Jul 2005300Highwire
Aug 2005300Highwire
Sep 2005100Highwire
Oct 2005100Highwire
Nov 2005200Highwire
Dec 20052200Highwire
Feb 2006900Highwire
Mar 2006600Highwire
Apr 2006600Highwire
May 2006200Highwire
Jun 2006100Highwire
Jul 2006100Highwire
Aug 2006200Highwire
Sep 2006100Highwire
Oct 2006200Highwire
Nov 2006200Highwire
Dec 20061000Highwire
Jan 2007100Highwire
Feb 2007400Highwire
Apr 2007200Highwire
May 2007100Highwire
Aug 2007100Highwire
Sep 2007100Highwire
Oct 2007100Highwire
Nov 2007300Highwire
Dec 2007400Highwire
Jan 2008600Highwire
Feb 20082000Highwire
Mar 20082200Highwire
Apr 20082200Highwire
May 20081200Highwire
Jun 2008500Highwire
Jul 2008500Highwire
Aug 2008700Highwire
Sep 2008200Highwire
Oct 20081500Highwire
Nov 20081200Highwire
Dec 20081900Highwire
Jan 20091500Highwire
Feb 20091100Highwire
Mar 20092600Highwire
Apr 20091700Highwire
May 2009500Highwire
Jun 2009300Highwire
Jul 2009100Highwire
Aug 2009200Highwire
Sep 2009600Highwire
Oct 2009900Highwire
Nov 20091300Highwire
Dec 2009800Highwire
Jan 20101110Highwire
Feb 2010800Highwire
Mar 2010600Highwire
Apr 2010700Highwire
May 2010800Highwire
Jun 2010200Highwire
Jul 2010100Highwire
Sep 2010500Highwire
Oct 20101500Highwire
Nov 2010401Highwire
Dec 20101500Highwire
Jan 20111500Highwire
Feb 20111900Highwire
Mar 20112000Highwire
Apr 20111800Highwire
May 20111700Highwire
Jun 20111910Highwire
Jul 20111000Highwire
Aug 2011500Highwire
Sep 2011831Highwire
Oct 20111000Highwire
Nov 20114500Highwire
Dec 20111200Highwire
Jan 20121700Highwire
Feb 20121500Highwire
Mar 20121900Highwire
Apr 20121501Highwire
May 20121400Highwire
Jun 20121000Highwire
Jul 2012900Highwire
Aug 20121001Highwire
Sep 20121300Highwire
Oct 20121001Highwire
Nov 2012700Highwire
Dec 2012900Highwire
Jan 2013800Highwire
Feb 2013600Highwire
Mar 2013200Highwire
Apr 20131401Highwire
May 2013800Highwire
Jun 2013600Highwire
Aug 2013501Highwire
Sep 2013300Highwire
Oct 20131500Highwire
Nov 2013300Highwire
Dec 2013100Highwire
Jan 2014300Highwire
Feb 2014100Highwire
Mar 2014500Highwire
Apr 2014200Highwire
May 2014300Highwire
Jun 2014400Highwire
Jul 20141000Highwire
Aug 2014500Highwire
Sep 2014400Highwire
Oct 20141001Highwire
Nov 2014301Highwire
Dec 2014601Highwire
Jan 2015800Highwire
Feb 2015100Highwire
Mar 2015500Highwire
Apr 2015600Highwire
May 2015700Highwire
Jun 20151800Highwire
Jul 20151301Highwire
Aug 2015500Highwire
Sep 2015400Highwire
Oct 2015201Highwire
Nov 2015110Highwire
Dec 2015100Highwire
Jan 2016300Highwire
Feb 2016400Highwire
Mar 20161111Highwire
Apr 2016800Highwire
May 2016900Highwire
Jun 2016600Highwire
Jul 2016700Highwire
Aug 2016500Highwire
Sep 2016101Highwire
Oct 2016500Highwire
Nov 2016400Highwire
Dec 2016300Highwire
Jan 2017700Highwire
Feb 2017701Highwire
Mar 2017500Highwire
Apr 2017501Highwire
May 2017500Highwire
Jun 2017500Highwire
Jul 2017100Highwire
Aug 2017700Highwire
Sep 2017900Highwire
Oct 2017801Highwire
Dec 2017300Highwire
Jan 20182100Highwire
Feb 2018402Highwire
Mar 2018400Highwire
Apr 2018200Highwire
May 2018600Highwire
Jun 2018210Highwire
Jul 2018502Highwire
Aug 2018300Highwire
Sep 2018500Highwire
Oct 2018500Highwire
Nov 2018400Highwire
Dec 2018500Highwire
Jan 2019300Highwire
Feb 2019300Highwire
Mar 2019700Highwire
Apr 2019300Highwire
May 2019400Highwire
Jun 2019100Highwire
Jul 20191401Highwire
Aug 2019300Highwire
Sep 2019300Highwire
Oct 2019710Highwire
Nov 20191510Highwire
Dec 2019200Highwire
Jan 2020500Highwire
Feb 2020411Highwire
Mar 2020710Highwire
Apr 2020801Highwire
May 2020400Highwire

Cited By...

Disputes & Debates: Rapid online correspondence

No comments have been published for this article.
Comment

NOTE: All authors' disclosures must be entered and current in our database before comments can be posted. Enter and update disclosures at http://submit.neurology.org. Exception: replies to comments concerning an article you originally authored do not require updated disclosures.

  • Stay timely. Submit only on articles published within the last 8 weeks.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • 200 words maximum.
  • 5 references maximum. Reference 1 must be the article on which you are commenting.
  • 5 authors maximum. Exception: replies can include all original authors of the article.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Disputes & Debates Submission Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Related Articles

  • No related articles found.

Alert Me